Capital Fund Management (CFM)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.16M | Sell |
10,500
-25,400
| -71% | -$13.8M | 0.02% | 877 |
|
|
2025
Q4 | $20.8M | Sell |
35,900
-147,700
| -80% | -$83.5M | 0.06% | 477 |
|
|
2025
Q3 | $89M | Sell |
183,600
-18,700
| -9% | -$8.7M | 0.23% | 76 |
|
|
2025
Q2 | $82M | Buy |
+202,300
| New | +$84.6M | 0.23% | 93 |
|
|
2025
Q1 | – | Sell |
-20,100
| Closed | -$10.5M | – | 2352 |
|
|
2024
Q4 | $10.5M | Buy |
20,100
+2,700
| +16% | +$1.48M | 0.03% | 738 |
|
|
2024
Q3 | $10.8M | Buy |
+17,400
| New | +$10.3M | 0.03% | 688 |
|
|
2024
Q2 | – | Sell |
-21,900
| Closed | -$12.7M | – | 2170 |
|
|
2024
Q1 | $12.7M | Sell |
21,900
-101,900
| -82% | -$57.2M | 0.04% | 626 |
|
|
2023
Q4 | $65.7M | Buy |
+123,800
| New | +$59.9M | 0.18% | 133 |
|
|
2023
Q3 | – | Sell |
-12,800
| Closed | -$6.68M | – | 2093 |
|
|
2023
Q2 | $6.68M | Buy |
+12,800
| New | +$6.91M | 0.03% | 726 |
|
|
2022
Q4 | – | Sell |
-20,900
| Closed | -$10.6M | – | 1630 |
|
|
2022
Q3 | $10.6M | Buy |
+20,900
| New | +$11.7M | 0.08% | 314 |
|
|
2022
Q2 | – | Sell |
-31,800
| Closed | -$18.8M | – | 1648 |
|
|
2022
Q1 | $18.8M | Buy |
+31,800
| New | +$18.3M | 0.15% | 183 |
|
|
2021
Q4 | – | Sell |
-17,200
| Closed | -$9.83M | – | 1857 |
|
|
2021
Q3 | $9.83M | Sell |
17,200
-1,500
| -8% | -$823K | 0.07% | 354 |
|
|
2021
Q2 | $9.43M | Buy |
+18,700
| New | +$8.82M | 0.07% | 352 |
|
|
2021
Q1 | – | Sell |
-37,400
| Closed | -$17.4M | – | 1602 |
|
|
2020
Q4 | $17.4M | Buy |
+37,400
| New | +$17.5M | 0.16% | 153 |
|
|
2020
Q1 | – | Sell |
-3,600
| Closed | -$1.17M | – | 2021 |
|
|
2019
Q4 | $1.17M | Sell |
3,600
-6,900
| -66% | -$2.09M | 0.01% | 1030 |
|
|
2019
Q3 | $3.06M | Sell |
10,500
-48,700
| -82% | -$13.9M | 0.03% | 643 |
|
|
2019
Q2 | $17.4M | Buy |
59,200
+47,500
| +406% | +$13.1M | 0.16% | 187 |
|
|
2019
Q1 | $3.2M | Buy |
11,700
+5,900
| +102% | +$1.47M | 0.03% | 640 |
|
|
2018
Q4 | $1.3M | Buy |
5,800
+1,100
| +23% | +$258K | 0.01% | 1012 |
|
|
2018
Q3 | $1.15M | Buy |
+4,700
| New | +$1.08M | 0.01% | 1325 |
|
|
2018
Q1 | – | Sell |
-2,600
| Closed | -$494K | – | 2175 |
|
|
2017
Q4 | $494K | Buy |
2,600
+1,400
| +117% | +$268K | ﹤0.01% | 1452 |
|
|
2017
Q3 | $227K | Sell |
1,200
-1,200
| -50% | -$217K | ﹤0.01% | 1417 |
|
|
2017
Q2 | $419K | Buy |
+2,400
| New | +$403K | ﹤0.01% | 1171 |
|
|
2016
Q4 | – | Sell |
-2,000
| Closed | -$318K | – | 1855 |
|
|
2016
Q3 | $318K | Buy |
2,000
+300
| +18% | +$46.2K | ﹤0.01% | 1359 |
|
|
2016
Q2 | $251K | Buy |
+1,700
| New | +$251K | ﹤0.01% | 1377 |
|
|
2016
Q1 | – | Sell |
-7,200
| Closed | -$1.02M | – | 1835 |
|
|
2015
Q4 | $1.02M | Buy |
+7,200
| New | +$960K | 0.01% | 877 |
|
|
2015
Q1 | – | Sell |
-5,200
| Closed | -$652K | – | 1725 |
|
|
2014
Q4 | $652K | Sell |
5,200
-200
| -4% | -$24.3K | 0.01% | 1038 |
|
|
2014
Q3 | $657K | Sell |
5,400
-43,800
| -89% | -$5.33M | 0.01% | 1069 |
|
|
2014
Q2 | $5.81M | Buy |
49,200
+15,100
| +44% | +$1.78M | 0.06% | 388 |
|
|
2014
Q1 | $4.1M | Buy |
34,100
+23,900
| +234% | +$2.84M | 0.05% | 437 |
|
|
2013
Q4 | $1.14M | Buy |
+10,200
| New | +$1.01M | 0.01% | 926 |
|
|
2013
Q3 | – | Sell |
-2,500
| Closed | -$212K | – | 1895 |
|
|
2013
Q2 | $212K | Buy |
+2,500
| New | +$208K | ﹤0.01% | 1233 |
|
Other funds holding TMO
VCM
Capital Fund Management (CFM)'s TMO Position: Q1 2026 in Review
Capital Fund Management (CFM) opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 22,205 shares worth $10.9M. The stake represents 0.05% of the portfolio and ranks #518 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in TMO as recently as Q2 2025.
Capital Fund Management (CFM) first reported a position in TMO in Q1 2014 and has held it in 14 quarters since. The position peaked at $53.5M in Q2 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Capital Fund Management (CFM) held 22,205 shares of Thermo Fisher Scientific worth $10.9M as of Q1 2026.
- Thermo Fisher Scientific was a new Capital Fund Management (CFM) position in Q1 2026.
- Thermo Fisher Scientific made up 0.05% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #518 holding.
- Capital Fund Management (CFM) first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 14 quarters since.
- Capital Fund Management (CFM)'s Thermo Fisher Scientific position peaked at $53.5M in Q2 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.